See more : Beken Corporation (603068.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Trupanion, Inc. (TRUP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Trupanion, Inc., a leading company in the Insurance – Specialty industry within the Financial Services sector.
- Nacity Property Service Group Co., Ltd. (603506.SS) Income Statement Analysis – Financial Results
- CF Energy Corp. (CGFEF) Income Statement Analysis – Financial Results
- Ralph Lauren Corporation (RL) Income Statement Analysis – Financial Results
- Evotec SE (EVT.SW) Income Statement Analysis – Financial Results
- Eco World Development Group Berhad (8206.KL) Income Statement Analysis – Financial Results
Trupanion, Inc. (TRUP)
About Trupanion, Inc.
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Puerto Rico, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians. The company was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013. The company was founded in 2000 and is headquartered in Seattle, Washington.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.11B | 905.18M | 698.99M | 502.03M | 383.94M | 303.96M | 242.67M | 188.23M | 146.96M | 115.91M | 83.83M | 55.53M | 37.05M |
Cost of Revenue | 977.59M | 782.99M | 594.65M | 420.13M | 319.01M | 252.59M | 199.62M | 154.94M | 121.73M | 96.04M | 68.19M | 44.32M | 29.00M |
Gross Profit | 131.02M | 122.19M | 104.35M | 81.90M | 64.92M | 51.37M | 43.05M | 33.29M | 25.23M | 19.87M | 15.64M | 11.21M | 8.04M |
Gross Profit Ratio | 11.82% | 13.50% | 14.93% | 16.31% | 16.91% | 16.90% | 17.74% | 17.68% | 17.17% | 17.15% | 18.66% | 20.19% | 21.71% |
Research & Development | 21.40M | 25.13M | 16.87M | 9.95M | 10.07M | 9.25M | 9.77M | 9.53M | 11.22M | 9.90M | 4.89M | 3.41M | 1.50M |
General & Administrative | 60.21M | 39.38M | 31.89M | 21.85M | 20.97M | 18.16M | 16.82M | 15.21M | 15.56M | 14.31M | 8.65M | 6.20M | 4.29M |
Selling & Marketing | 0.00 | 89.50M | 78.65M | 47.84M | 35.45M | 25.00M | 19.10M | 15.25M | 15.23M | 11.61M | 9.09M | 7.15M | 5.21M |
SG&A | 60.21M | 128.88M | 110.54M | 69.68M | 56.42M | 43.16M | 35.92M | 30.45M | 30.79M | 25.92M | 17.74M | 13.34M | 9.50M |
Other Expenses | 90.07M | 10.92M | 11.97M | 7.07M | 1.63M | 1.31M | 1.24M | -37.00K | 9.00K | 1.49M | -42.00K | -98.00K | -1.00K |
Operating Expenses | 171.68M | 164.93M | 139.37M | 86.70M | 66.49M | 52.41M | 45.69M | 39.99M | 42.00M | 35.82M | 22.63M | 16.75M | 10.99M |
Cost & Expenses | 1.15B | 947.93M | 734.02M | 506.83M | 385.50M | 305.00M | 245.31M | 194.93M | 163.74M | 131.86M | 90.82M | 61.07M | 40.00M |
Interest Income | 0.00 | 3.00M | 10.00K | 1.38M | 1.35M | 0.00 | 0.00 | 119.00K | 75.00K | 73.00K | 86.00K | 75.00K | 69.00K |
Interest Expense | 12.08M | 4.27M | 10.00K | 1.38M | 1.35M | 1.20M | 533.00K | 218.00K | 325.00K | 6.73M | 609.00K | 535.00K | 690.00K |
Depreciation & Amortization | 12.47M | 10.92M | 11.97M | 7.07M | 5.63M | 4.51M | 4.23M | 3.85M | 2.54M | 1.67M | 892.00K | 349.00K | 199.00K |
EBITDA | -20.48M | -29.01M | -23.25M | 2.73M | 5.34M | 4.78M | 2.83M | -2.79M | -14.22M | -12.78M | -6.77M | -5.44M | -2.94M |
EBITDA Ratio | -1.85% | -3.20% | -3.33% | 0.54% | 1.39% | 1.57% | 1.17% | -1.47% | -9.68% | -11.03% | -7.28% | -9.39% | -7.25% |
Operating Income | -40.66M | -42.75M | -35.03M | -4.35M | -291.00K | -1.05M | -2.64M | -6.70M | -16.78M | -15.95M | -6.99M | -5.54M | -2.95M |
Operating Income Ratio | -3.67% | -4.72% | -5.01% | -0.87% | -0.08% | -0.34% | -1.09% | -3.56% | -11.41% | -13.76% | -8.33% | -9.97% | -7.97% |
Total Other Income/Expenses | -4.38M | -1.20M | -24.00K | -800.00K | 280.00K | 111.00K | 711.00K | -160.00K | -316.00K | -5.24M | -1.28M | -787.00K | -876.00K |
Income Before Tax | -45.04M | -44.20M | -35.22M | -5.73M | -1.64M | -934.00K | -1.93M | -6.86M | -17.09M | -21.18M | -8.27M | -6.33M | -3.83M |
Income Before Tax Ratio | -4.06% | -4.88% | -5.04% | -1.14% | -0.43% | -0.31% | -0.80% | -3.64% | -11.63% | -18.28% | -9.86% | -11.39% | -10.33% |
Income Tax Expense | -342.00K | 476.00K | 310.00K | 113.00K | 169.00K | -7.00K | -428.00K | 38.00K | 114.00K | -7.00K | -92.00K | 84.00K | 92.00K |
Net Income | -44.69M | -44.67M | -35.53M | -5.84M | -1.81M | -927.00K | -1.50M | -6.90M | -17.21M | -21.18M | -8.18M | -6.41M | -3.92M |
Net Income Ratio | -4.03% | -4.94% | -5.08% | -1.16% | -0.47% | -0.30% | -0.62% | -3.66% | -11.71% | -18.27% | -9.75% | -11.54% | -10.58% |
EPS | -1.08 | -1.10 | -0.89 | -0.16 | -0.05 | -0.03 | -0.05 | -0.24 | -0.62 | -0.76 | -6.23 | -4.18 | -0.21 |
EPS Diluted | -1.08 | -1.10 | -0.89 | -0.16 | -0.05 | -0.03 | -0.05 | -0.24 | -0.62 | -0.76 | -6.23 | -4.18 | -0.21 |
Weighted Avg Shares Out | 41.44M | 40.77M | 40.14M | 35.86M | 34.65M | 31.96M | 29.59M | 28.53M | 27.64M | 27.83M | 1.31M | 1.53M | 18.37M |
Weighted Avg Shares Out (Dil) | 41.44M | 40.77M | 40.14M | 35.86M | 34.65M | 31.96M | 29.59M | 28.53M | 27.64M | 27.83M | 1.31M | 1.53M | 18.37M |
Trupanion Announces Winners of the Veterinary Appreciation Day™ Awards
3 Short-Squeeze Stocks to Buy Before July for 20% Returns
These 5 stocks are potential short-squeeze candidates
Trupanion: Growth First, Profitability Second
WakeMed Selects Bamboo Health to Drive Improved Care Coordination for Patients
Boehringer Ingelheim & Trupanion Announce Exclusive Collaboration to Increase Access to Pet Care
3 Oversold Stocks Down 70% to Buy on the Dip Before They Rebound
Trupanion (TRUP) Rallies 27% in a Year: More Upside Left?
If You Can Only Buy One Meme Stock Now, It Better Be One of These 3 Names
Barking Up the Right Tree: 3 Top Pet Stocks With ‘Pawsitive' Returns
Source: https://incomestatements.info
Category: Stock Reports